Ian is a business lawyer with more than 20 years of experience advising emerging growth companies in the technology and life sciences industries, as well as the strategic investors that finance, partner with and acquire these companies. He also advises companies and institutions that are adapting to a technology-driven world on complex financial and strategic transactions and other initiatives designed to accelerate innovation and growth. Ian’s practice is based in the growing and dynamic technology and venture market of New York City and leverages the knowledge, insights and connections of the firm’s deep roots in Silicon Valley.
Ian heads up the firm’s corporate venture practice team and is a leading voice in the representation of the corporate venture community. He regularly advises many of the world’s most active and influential strategic investors, as well as emerging players in the CVC community, in fund formation and strategy matters, venture financing execution, portfolio company oversight and exits, and a variety of other innovative transactions.
Ian also represents dozens of entrepreneurs and growing businesses in a variety of technology and life sciences sectors, including software, hardware, consumer, media, digital health and life sciences. He regularly serves as an “outside general counsel” for his emerging growth clients, leading a team of Fenwick lawyers who handle critical business and legal matters for his clients on a daily basis.
Prior to joining Fenwick, Ian was a partner at an Am Law 100 firm where he served as vice-chair of that firm’s corporate practice and led the firm’s emerging company and venture practice team.
- 3M Ventures
- AbbVie Ventures
- EPAM Systems
- Fitch Ventures
- Hearst Ventures
- Johnson & Johnson
- Kinnevik AB
- Merck Global Health Innovation
- MRL Ventures
- P&G Ventures
- Prelude Therapeutics
- Rivet Labs
- Standard Industries
- Sterling Equities
Education & Admissions
J.D., with honors, Rutgers Law School
Admitted to practice in New York and New Jersey